Viridian Therapeutics
VRDN
VRDN
135 hedge funds and large institutions have $1.1B invested in Viridian Therapeutics in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.05% less ownership
Funds ownership: 102.45% → 100.39% (-2.1%)
9% less capital invested
Capital invested by funds: $1.21B → $1.1B (-$110M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
135
Holding in Top 10
7
Calls
$7.59M
Puts
$2.19M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$26.5M | |
| 3 | +$14.4M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$14M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.7M |
Top Sellers
| 1 | -$28.5M | |
| 2 | -$27.2M | |
| 3 | -$13.8M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$12.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$9.88M |